Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Exercise × Gynecologic × Clear all

Phase

Phase NA 14 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6 Thoracic 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Ovarian Neoplasms 1 Motor Activity 1 Fatigue 1 Body Weight 1

Interventions

Paclitaxel 124 Carboplatin 91 Cisplatin 74 Bevacizumab 34 Gemcitabine 30 Topotecan 28 liposomal doxorubicin 26 Radiotherapy 26 Doxorubicin 25 Brachytherapy 23 Taxes 22 olaparib 17 Drug Therapy 17 pembrolizumab 16 Chemotherapy, Adjuvant 15 human papillomavirus vaccine, L1 type 16, 18 13 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 13 Docetaxel 12 Hyperthermic Intraperitoneal Chemotherapy 11 niraparib 9 Radiation 9 Platinum 9 Neoadjuvant Therapy 9 Vaccines, Synthetic 8 Surgical Procedures, Operative 7 Specimen Handling 7 Papillomavirus Vaccines 7 Dexamethasone 7 1,2-diaminocyclohexaneplatinum II citrate 7 mirvetuximab soravtansine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02107066 2018-04-20

WALC

Yale University

Phase 3 Completed

Body Weight, Fatigue, Motor Activity, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡